Delivery Order SPE2DE24D0013-SPE2D626F11NC
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $8,160 on November 13, 2025, with an ultimate completion date of November 20, 2025. This delivery order, designated XPRS4PLEX-10, was issued without a set-aside designation and is to be performed at Cepheid's headquarters in Sunnyvale, California. The contract represents a continuation of Cepheid's ongoing supply relationship with the federal government as a primary provider of...
- The Defense Logistics Agency Medical Supply Chain awarded a $19,040 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, with an ultimate completion date of January 22, 2026. This delivery order, issued under the XPRS4PLEX-10 contract vehicle, represents a child contract with no set-aside designation. The work will be performed at Cepheid's headquarters in Sunnyvale, California. As a leading manufacturer of molecular diagnostic systems and reagents, Cepheid has established itself...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20.4K to Cepheid Inc. on January 13, 2026, for diagnostic testing supplies and reagents. This delivery order, designated XPRS4PLEX-10, is a child contract under a larger Indefinite Delivery Vehicle and carries a firm fixed-price structure with no set-aside designation. The order is scheduled for completion by January 21, 2026, and will be performed at Cepheid's headquarters location in Sunnyvale, California....
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls...
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,024 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. This delivery order, designated XPRSTREPA-10 (4570410034), carries no set-aside designation and represents procurement of diagnostic testing supplies and reagents from Cepheid's established federal product portfolio....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,160 to Cepheid Inc. on January 14, 2026, for diagnostic testing supplies under the XPRS4PLEX-10 contract vehicle. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a child order issued against Cepheid's larger Indefinite Delivery Contracts with the Department of Veterans Affairs. The award carries no set-aside designation, reflecting Cepheid's competitive...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F11NCDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $13,096.80 firm fixed-price delivery order to Cepheid Inc. on January 15, 2026, with completion scheduled for January 23, 2026. This delivery order, issued under the contract vehicle XPRS4PLEX-10, represents a child contract with no set-aside designation and is expected to be performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal supplier of molecular diagnostic systems and reagents, Cepheid specializes in providing rapid diagnostic testing solutions for infectious diseases, including respiratory pathogens, through its GeneXpert platform. This delivery order falls within Cepheid's broader federal contracting portfolio supporting the Defense Health Agency and other federal healthcare entities. The company maintains significant indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million vehicle with VISN 6 extending through September 2030, which establishes the framework for ongoing procurement of molecular diagnostic testing supplies and reagents across VA medical centers. The modest ceiling value of the current delivery order reflects routine replenishment of diagnostic test cartridges and supplies needed to support federal clinical laboratory operations and infectious disease testing requirements across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 1/14/26 |